S&P 500   3,322.86 (-1.02%)
DOW   27,716.27 (-0.67%)
QQQ   266.31 (-1.48%)
AAPL   107.54 (-2.54%)
MSFT   199.70 (-1.58%)
FB   253.29 (-0.60%)
GOOGL   1,442.90 (-2.97%)
AMZN   2,942.23 (-2.21%)
NVDA   487.17 (-2.28%)
TSLA   444.07 (+4.87%)
BABA   273.43 (-0.83%)
CGC   16.33 (-0.43%)
GE   6.91 (-1.99%)
MU   50.74 (-0.47%)
AMD   74.98 (-2.05%)
T   28.95 (-0.41%)
F   7.24 (-0.55%)
ACB   6.44 (-6.53%)
GILD   65.00 (-0.06%)
NFLX   464.87 (-1.13%)
DIS   129.42 (-0.61%)
BAC   25.31 (-0.16%)
BA   162.02 (-3.29%)
S&P 500   3,322.86 (-1.02%)
DOW   27,716.27 (-0.67%)
QQQ   266.31 (-1.48%)
AAPL   107.54 (-2.54%)
MSFT   199.70 (-1.58%)
FB   253.29 (-0.60%)
GOOGL   1,442.90 (-2.97%)
AMZN   2,942.23 (-2.21%)
NVDA   487.17 (-2.28%)
TSLA   444.07 (+4.87%)
BABA   273.43 (-0.83%)
CGC   16.33 (-0.43%)
GE   6.91 (-1.99%)
MU   50.74 (-0.47%)
AMD   74.98 (-2.05%)
T   28.95 (-0.41%)
F   7.24 (-0.55%)
ACB   6.44 (-6.53%)
GILD   65.00 (-0.06%)
NFLX   464.87 (-1.13%)
DIS   129.42 (-0.61%)
BAC   25.31 (-0.16%)
BA   162.02 (-3.29%)
S&P 500   3,322.86 (-1.02%)
DOW   27,716.27 (-0.67%)
QQQ   266.31 (-1.48%)
AAPL   107.54 (-2.54%)
MSFT   199.70 (-1.58%)
FB   253.29 (-0.60%)
GOOGL   1,442.90 (-2.97%)
AMZN   2,942.23 (-2.21%)
NVDA   487.17 (-2.28%)
TSLA   444.07 (+4.87%)
BABA   273.43 (-0.83%)
CGC   16.33 (-0.43%)
GE   6.91 (-1.99%)
MU   50.74 (-0.47%)
AMD   74.98 (-2.05%)
T   28.95 (-0.41%)
F   7.24 (-0.55%)
ACB   6.44 (-6.53%)
GILD   65.00 (-0.06%)
NFLX   464.87 (-1.13%)
DIS   129.42 (-0.61%)
BAC   25.31 (-0.16%)
BA   162.02 (-3.29%)
S&P 500   3,322.86 (-1.02%)
DOW   27,716.27 (-0.67%)
QQQ   266.31 (-1.48%)
AAPL   107.54 (-2.54%)
MSFT   199.70 (-1.58%)
FB   253.29 (-0.60%)
GOOGL   1,442.90 (-2.97%)
AMZN   2,942.23 (-2.21%)
NVDA   487.17 (-2.28%)
TSLA   444.07 (+4.87%)
BABA   273.43 (-0.83%)
CGC   16.33 (-0.43%)
GE   6.91 (-1.99%)
MU   50.74 (-0.47%)
AMD   74.98 (-2.05%)
T   28.95 (-0.41%)
F   7.24 (-0.55%)
ACB   6.44 (-6.53%)
GILD   65.00 (-0.06%)
NFLX   464.87 (-1.13%)
DIS   129.42 (-0.61%)
BAC   25.31 (-0.16%)
BA   162.02 (-3.29%)
Log in
NYSE:VAR

Varian Medical Systems Stock Forecast, Price & News

$173.29
-0.21 (-0.12 %)
(As of 09/18/2020 03:15 PM ET)
Add
Compare
Today's Range
$173.03
Now: $173.29▼
$173.50
50-Day Range
$136.55
MA: $170.02▼
$174.66
52-Week Range
$89.62
Now: $173.29▼
$176.19
Volume32,118 shs
Average Volume1.02 million shs
Market Capitalization$15.76 billion
P/E Ratio56.45
Dividend YieldN/A
Beta1.2
Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Proton Solutions. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, as well as related quality assurance equipment. Its products include linear accelerators, brachytherapy after loaders, treatment accessories, and quality assurance software; and information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians' offices, medical oncology practices, radiotherapy centers, and cancer care clinics. The Proton Solutions segment designs, develops, manufactures, sells, and services products and systems for delivering proton therapy for the treatment of cancer. Varian Medical Systems, Inc. has a strategic partnership with Siemens AG to co-develop new imaging and treatment solutions; and a strategic cooperation framework agreement with Shandong Cancer Hospital for proton therapy clinical application and research in China. The company was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. Varian Medical Systems, Inc. was founded in 1948 and is headquartered in Palo Alto, California.
Read More
Varian Medical Systems logo

Beat the Market (BTM) Rank™

Analyst Opinion: 1.1Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

1.20 out of 5 stars


Industry, Sector and Symbol

Stock Exchange NYSE
Industry Electromedical equipment
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNYSE:VAR
Previous Symbol
CUSIP92220P10
CIK203527
Webwww.varian.com
Phone650-493-4000

Debt

Debt-to-Equity RatioN/A
Current Ratio1.32
Quick Ratio1.02

Price-To-Earnings

Trailing P/E Ratio56.45
Forward P/E Ratio45.84
P/E GrowthN/A

Sales & Book Value

Annual Sales$3.23 billion
Price / Sales4.89
Cash Flow$5.69 per share
Price / Cash Flow30.43
Book Value$19.52 per share
Price / Book8.88

Profitability

EPS (Most Recent Fiscal Year)$4.63
Net Income$291.90 million
Net Margins8.82%
Return on Equity19.68%
Return on Assets8.45%

Miscellaneous

Employees10,062
Outstanding Shares90,941,000
Market Cap$15.76 billion
Next Earnings Date10/28/2020 (Estimated)
OptionableOptionable
$173.29
-0.21 (-0.12 %)
(As of 09/18/2020 03:15 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive VAR News and Ratings via Email

Sign-up to receive the latest news and ratings for VAR and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Varian Medical Systems (NYSE:VAR) Frequently Asked Questions

How has Varian Medical Systems' stock price been impacted by Coronavirus?

Varian Medical Systems' stock was trading at $113.04 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, VAR shares have increased by 53.3% and is now trading at $173.24.
View which stocks have been most impacted by COVID-19.

Do Wall Street analysts recommend investors buy shares of Varian Medical Systems?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Varian Medical Systems in the last year. There are currently 2 sell ratings, 4 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Varian Medical Systems.

When is Varian Medical Systems' next earnings date?

Varian Medical Systems is scheduled to release its next quarterly earnings announcement on Wednesday, October 28th 2020.
View our earnings forecast for Varian Medical Systems.

How were Varian Medical Systems' earnings last quarter?

Varian Medical Systems, Inc. (NYSE:VAR) released its quarterly earnings data on Sunday, August, 2nd. The medical equipment provider reported $0.78 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.55 by $0.23. The medical equipment provider earned $694.30 million during the quarter, compared to the consensus estimate of $677.13 million. Varian Medical Systems had a net margin of 8.82% and a return on equity of 19.68%.
View Varian Medical Systems' earnings history.

What price target have analysts set for VAR?

9 brokerages have issued twelve-month price objectives for Varian Medical Systems' stock. Their forecasts range from $90.00 to $178.00. On average, they anticipate Varian Medical Systems' stock price to reach $144.39 in the next twelve months. This suggests that the stock has a possible downside of 16.7%.
View analysts' price targets for Varian Medical Systems.

What are Wall Street analysts saying about Varian Medical Systems stock?

Here are some recent quotes from research analysts about Varian Medical Systems stock:
  • 1. According to Zacks Investment Research, "Varian continues to gain from its core Oncology Systems segment, which saw solid overseas growth, especially in EMEA and China. In fact, management foresees tremendous opportunities in China owing to the recent tariff exclusions. Gross orders surged in the quarter. Management is optimistic about the recently-closed acquisitions of CyberHeart, Cancer Treatment Services International, Endocare and Alicon. Expansion in gross margin is an added positive. Varian retained its outlook for fiscal 2020. On the flip side, the Proton Solutions unit was weak in the quarter. Moreover, Varian saw some softness in orders in Japan. Economic stagnation due to coronavirus outbreak has been another dampener. Reflective of these, the stock has underperformed the industry in a year’s time. Varian exited the fiscal first quarter on a weak note." (4/10/2020)
  • 2. Barrington Research analysts commented, "We strongly suspect that radiation that is delivered via the Ethos system will receive very high marks from both clinicians and patients alike. Ethos currently has its CE Mark while a 510(k) regulatory clearance in the U.S. is still pending." (9/23/2019)

Are investors shorting Varian Medical Systems?

Varian Medical Systems saw a increase in short interest in August. As of August 31st, there was short interest totaling 4,490,000 shares, an increase of 53.2% from the August 15th total of 2,930,000 shares. Based on an average trading volume of 1,350,000 shares, the days-to-cover ratio is currently 3.3 days. Approximately 4.9% of the shares of the stock are sold short.
View Varian Medical Systems' Short Interest.

Who are some of Varian Medical Systems' key competitors?

Some companies that are related to Varian Medical Systems include Abbott Laboratories (ABT), Medtronic (MDT), Intuitive Surgical (ISRG), Stryker (SYK), Becton Dickinson and (BDX), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), DexCom (DXCM), IDEXX Laboratories (IDXX), ResMed (RMD), Hologic (HOLX), Teleflex (TFX), Insulet (PODD) and Steris (STE).
View all competitors.

What other stocks do shareholders of Varian Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Varian Medical Systems investors own include NVIDIA (NVDA), Abbott Laboratories (ABT), Gilead Sciences (GILD), Pfizer (PFE), CVS Health (CVS), Netflix (NFLX), Visa (V), Intel (INTC), Johnson & Johnson (JNJ) and Coca-Cola (KO).

Who are Varian Medical Systems' key executives?

Varian Medical Systems' management team includes the following people:
  • Mr. Dow R. Wilson, Pres, CEO & Director (Age 60)
  • Mr. Gary E. Bischoping Jr., Sr. VP of Fin. & CFO (Age 51)
  • Mr. John W. Kuo, Sr. VP, Gen. Counsel & Corp. Sec. (Age 56)
  • Ms. Kolleen T. Kennedy, Chief Growth Officer & Pres of Proton Solutions (Age 60)
  • Mr. Kevin O'Reilly, Sr. VP of Global Operations

What is Varian Medical Systems' stock symbol?

Varian Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "VAR."

Who are Varian Medical Systems' major shareholders?

Varian Medical Systems' stock is owned by a number of institutional and retail investors. Top institutional investors include Nordea Investment Management AB (1.98%), First Eagle Investment Management LLC (1.47%), APG Asset Management N.V. (1.24%), Bank of America Corp DE (1.13%), FMR LLC (1.04%) and Mitsubishi UFJ Trust & Banking Corp (0.93%). Company insiders that own Varian Medical Systems stock include Christopher A Toth, Dow R Wilson, Gary E Bischoping Jr, John W Kuo, Kolleen T Kennedy, Magnus Momsen, R Andrew Eckert and Timothy E Guertin.
View institutional ownership trends for Varian Medical Systems.

Which institutional investors are selling Varian Medical Systems stock?

VAR stock was sold by a variety of institutional investors in the last quarter, including Marshall Wace North America L.P., Viking Global Investors LP, FMR LLC, Bank of America Corp DE, First Trust Advisors LP, AQR Capital Management LLC, Dana Investment Advisors Inc., and Assenagon Asset Management S.A.. Company insiders that have sold Varian Medical Systems company stock in the last year include Christopher A Toth, Dow R Wilson, John W Kuo, Kolleen T Kennedy, Magnus Momsen, and R Andrew Eckert.
View insider buying and selling activity for Varian Medical Systems.

Which institutional investors are buying Varian Medical Systems stock?

VAR stock was acquired by a variety of institutional investors in the last quarter, including Nordea Investment Management AB, APG Asset Management N.V., Mitsubishi UFJ Trust & Banking Corp, Alyeska Investment Group L.P., Sumitomo Mitsui Trust Holdings Inc., London Co. of Virginia, Montrusco Bolton Investments Inc., and New York State Common Retirement Fund.
View insider buying and selling activity for Varian Medical Systems.

How do I buy shares of Varian Medical Systems?

Shares of VAR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Varian Medical Systems' stock price today?

One share of VAR stock can currently be purchased for approximately $173.24.

How big of a company is Varian Medical Systems?

Varian Medical Systems has a market capitalization of $15.75 billion and generates $3.23 billion in revenue each year. The medical equipment provider earns $291.90 million in net income (profit) each year or $4.63 on an earnings per share basis. Varian Medical Systems employs 10,062 workers across the globe.

What is Varian Medical Systems' official website?

The official website for Varian Medical Systems is www.varian.com.

How can I contact Varian Medical Systems?

Varian Medical Systems' mailing address is 3100 Hansen Way, Palo Alto CA, 94304. The medical equipment provider can be reached via phone at 650-493-4000 or via email at [email protected]

This page was last updated on 9/18/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.